JPH0354550B2 - - Google Patents
Info
- Publication number
- JPH0354550B2 JPH0354550B2 JP18606186A JP18606186A JPH0354550B2 JP H0354550 B2 JPH0354550 B2 JP H0354550B2 JP 18606186 A JP18606186 A JP 18606186A JP 18606186 A JP18606186 A JP 18606186A JP H0354550 B2 JPH0354550 B2 JP H0354550B2
- Authority
- JP
- Japan
- Prior art keywords
- medium
- glutamic acid
- lysozyme
- culture
- biotin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
本発明はコリネバクテリウム属またはブレビバ
クテリウム属に属し、リゾチームに感受性を有
し、培地中に存在する過剰のビオチンによつてL
−グルタミン酸の生産が抑制されないL−グルタ
ミン酸生産性新規微生物に関する。
生育にビオチンを要求するL−グルタミン酸生
産菌のL−グルタミン酸生産性は培地中のビオチ
ン濃度と極めて密接な関係があり、生育に対して
制限量のビオチン濃度のときはじめてL−グルタ
ミン酸を生産できる。一方安価な培地の粗原料と
して利用される廃糖蜜、殿粉加水分解物などはビ
チオンを多量に含有している。これら粗原料を含
有する培地にL−グルタミン酸生産菌を培養する
方法としては特公昭37−1695号公報、特公昭38−
25288号公報などに記載されている方法が知られ
ているが、工業的にはさらに優れた方法が望まれ
ている。
本発明者らは、安価な粗原料を用い、過剰量の
ビチオンの作用を回避してL−グルタミン酸を製
造する方法につき研究した結果、従来のL−グル
タミン酸生産菌を親株として変異誘導したリゾチ
ームに感受性を有する変異株を用いれば、過剰の
ビオチン含有培地を用いても、ビオチンによる抑
制を受けることなく高い収率でL−グルタミン酸
を生産できることを見出した。
以下本発明をさらに詳細に説明する。
本発明によればコリネバクテリウム属またはブ
レビバクテリウム属に属し、リゾチームに感受性
を有し、培地中に存在する過剰のビオチンによつ
てL−グルタミン酸の生産が抑制されない性質を
有する微生物を培地に培養すれば培地中にL−グ
ルタミン酸が蓄積するので、これを採取すること
により高収率にL−グルタミン酸が得られる。
本発明に用いる微生物はコリネバクテリウム属
またはブレビバクテリウム属に属し、リゾチーム
に感受性を有し、培地中に存在する過剰のビオチ
ンによつてL−グルタミン酸の生産が抑制されな
い性質を有する微生物であればいかなる菌株をも
用いることができる。一般にはコリネバクテリウ
ム属またはブレビバクテリウム属に属し、L−グ
ルタミン酸生産能を有する菌株を親株とし、これ
を変異誘導処理して得られた変異株からリゾチー
ムに感受性を有するものを選択し、これを用い
る。変異誘導の方法としては、紫外線照射、放射
線照射、変異誘起剤処理等の通常の方法が用いら
れる。変異誘導された変異株からリゾチームに感
受性を有する菌株を選択するには、親株が生育可
能な濃度のリゾチームを含有する培地で生育でき
なくて、リゾチーム無添加培地では親株と同様に
生育できるものを選べばよい。従つて、ここでリ
ゾチームに感受性であることは、リゾチームに対
する最小阻止濃度が親株より低いことを意味す
る。また培地中に存在する過剰のビオチンによつ
てL−グルタミン酸の生産が抑制されないとは、
培地中に存在する過剰のビオチンによるL−グル
タミン酸生産の抑制が実質的に無視できる程度の
ものであることを意味する。具体的には前記のご
とき粗原料を用いた場合でも過剰のビオチンによ
る影響をうけることなくL−グルタミン酸の生産
ができることを意味する。
本発明に用いる具体的に好適な菌株の一例とし
ては、コリネバクテリウム・グルタミクム
ATCC13032を親株として得られたコリネバクテ
リウム・グルタミクムKY9703(微工研菌寄第
4412号、NRRL11271)、コリネバクテリウム・
グルタミクムKY9705(微工研菌寄第4413号、
NRRL11272)およびブレビバクテリウム・フラ
ブムATCC14067を親株として得られたブレビバ
クテリウム・フラブムKY9733(微工研菌寄第
4414号、NRRL11273)があげられる。
コリネバクテリウム・グルタミクム
ATCC13032を親株としてリゾチーム感受性変異
株を取得する方法について以下具体的に説明す
る。該親株を粉末ブイヨン(極東製薬社製)20
g/および酵母エキス5g/の組成を有する
培地(殺菌前PH7.2、以下C培地という)に植菌
し30℃で振盪培養する。中期対数期で培養を中止
し、集菌し、生理食塩水で洗浄後、M/20トリ
ス・マレート緩衝液(PH6.0)に5×108細胞/ml
になるように懸濁する。この懸濁液に最終濃度
500μg/mlになるようにニトロソグアニジンを
加え、25℃で30分間放置し、遠心分離により菌体
を集め、同一緩衝液で菌体を洗浄後、生理食塩水
に懸濁し、適宜生理食塩水で希釈してC培地にさ
らに2g/dlの寒天を含む固体培地(以下CA培
地という)に塗りつける。これを30℃で2日間培
養し、生じたコロニー(約6000)を次の3種類の
固体培地にレプリカ法により塗りつける。
CA培地
CLA培地:CA培地を加熱殺菌後、冷却して
培地の温度が45℃まで下がつてから200mg/
になるようにリゾチームを添加した培地。
MA培地:グルコース10g/、NH4Cl4
g/、尿素2g/、KH2PO41g/、
K2HPO4 3g/、FeSO4・7H2O 10mg/、
MgSO4・7H2O 400mg/、MnCl2・4H2O 2
mg/、ZnSO4・7H2O 0.9mg/、CuSO4・
5H2O 0.4mg/、Na2B4O7・10H2O 0.09mg/
、(NH4)6Mo7O24・4H2O 0.04mg/、ビオ
チン30μg/、サイアミン塩酸塩1mg/、
システイン塩酸塩20mg/および寒天20g/
の組成を有する培地(殺菌前PH7.0)。
30℃で2日間培養後、CA培地で生育し、CLA
培地で生育しない菌をリゾチーム感受性変異株と
して得る。MA培地で親株と同様に生育する自己
栄養性でリゾチームに対して感受性の変異株は試
験した6000コロニーの中に110株得られた。この
110株中17株がビオチン過剰培地でも多量のL−
グルタミン酸を生育する能力を有していた。コリ
ネバクテリウム・グルタミクムKY9703および
KY9705はかくして得られた変異株の一例であ
る。
ブレビバクテリウム・フラブムATCC14067を
親株とする変異誘導も上記と同様に行つて、ブレ
ビバクテリウム・フラブムKY9733を得た。
上記例示の変異株とMA培地、CA培地、CLA
培地での生育およびリゾチーム感受性度について
親株と比較した結果を第1表に示す。3種類の固
体培地上での生育はレプリカ法で塗りつけ、30℃
で2日間培養後判定した。表中生育欄の+は菌の
生育が観察されたものを、−は生育が観察されな
かつたものを示す。また表中リゾチーム感受性は
次のように試験した。すなわちC培地にて24時間
30℃液体振盪培養した菌を集菌後、生理食塩水に
て適当に希釈して菌体の懸濁液をつくる。この懸
濁液104細胞相当を倍々系列の濃度のリゾチーム
を含有するCA培地に滴下接種し、30℃で2日間
培養する。菌の生育がまつたくみとめめられない
最小のリゾチーム濃度を菌のリゾチーム感受性値
(最小生育阻止濃度)とした。
The present invention belongs to the genus Corynebacterium or Brevibacterium, and is sensitive to lysozyme, and is caused by excess biotin present in the medium.
- A novel microorganism capable of producing L-glutamic acid whose production of glutamic acid is not suppressed. The L-glutamic acid productivity of L-glutamic acid-producing bacteria that requires biotin for growth is extremely closely related to the biotin concentration in the medium, and L-glutamic acid can only be produced when the biotin concentration is at a limiting amount for growth. On the other hand, blackstrap molasses, starch hydrolyzate, and the like, which are used as crude raw materials for inexpensive culture media, contain large amounts of bithione. Methods for culturing L-glutamic acid producing bacteria in a medium containing these crude materials are disclosed in Japanese Patent Publication No. 37-1695 and Japanese Patent Publication No. 38-1989.
Although the method described in Japanese Patent No. 25288 is known, an even better method is desired from an industrial perspective. The present inventors conducted research on a method for producing L-glutamic acid using inexpensive crude raw materials and avoiding the effects of excessive amounts of bithione. It has been found that by using a sensitive mutant strain, L-glutamic acid can be produced in high yield without being inhibited by biotin even if an excess biotin-containing medium is used. The present invention will be explained in more detail below. According to the present invention, a microorganism belonging to the genus Corynebacterium or Brevibacterium, sensitive to lysozyme, and having the property that the production of L-glutamic acid is not suppressed by excess biotin present in the medium is used in a medium. When cultured, L-glutamic acid accumulates in the medium, and by collecting this, L-glutamic acid can be obtained in high yield. The microorganism used in the present invention belongs to the genus Corynebacterium or Brevibacterium, is sensitive to lysozyme, and has the property that the production of L-glutamic acid is not inhibited by excess biotin present in the culture medium. Any bacterial strain can be used. In general, a strain belonging to the genus Corynebacterium or Brevibacterium and having the ability to produce L-glutamic acid is used as a parent strain, and a strain sensitive to lysozyme is selected from the mutant strains obtained by mutagenesis treatment. Use. As a method for inducing mutations, conventional methods such as ultraviolet irradiation, radiation irradiation, and treatment with a mutagenic agent are used. To select strains sensitive to lysozyme from mutagenized mutant strains, select strains that cannot grow in a medium containing lysozyme at a concentration that allows the parent strain to grow, but can grow in the same manner as the parent strain in a medium without lysozyme. All you have to do is choose. Therefore, being sensitive to lysozyme here means that the minimum inhibitory concentration for lysozyme is lower than that of the parent strain. Furthermore, the production of L-glutamic acid is not suppressed by excess biotin present in the medium.
This means that the inhibition of L-glutamic acid production by excess biotin present in the medium is substantially negligible. Specifically, this means that L-glutamic acid can be produced without being affected by excess biotin even when using the above-mentioned crude raw materials. As an example of a specifically suitable strain for use in the present invention, Corynebacterium glutamicum
Corynebacterium glutamicum KY9703 obtained using ATCC13032 as the parent strain
No. 4412, NRRL11271), Corynebacterium
Glutamicum KY9705 (Feikoken Bacillus No. 4413,
NRRL11272) and Brevibacterium flavum KY9733 obtained using Brevibacterium flavum ATCC14067 as the parent strain
No. 4414, NRRL11273). Corynebacterium glutamicum
A method for obtaining a lysozyme-sensitive mutant strain using ATCC13032 as a parent strain will be specifically described below. The parent strain was added to powdered broth (Kyokuto Pharmaceutical Co., Ltd.) 20
The cells were inoculated into a medium (PH 7.2 before sterilization, hereinafter referred to as C medium) having a composition of 5 g/g and yeast extract and cultured with shaking at 30°C. The culture was stopped at mid-logarithmic phase, the bacteria were harvested, and after washing with physiological saline, the cells were added to M/20 Tris-malate buffer (PH6.0) at 5 x 10 8 cells/ml.
Suspend so that This suspension has a final concentration of
Add nitrosoguanidine to a concentration of 500 μg/ml, leave at 25°C for 30 minutes, collect bacterial cells by centrifugation, wash the cells with the same buffer, suspend in physiological saline, and add physiological saline as appropriate. Dilute and spread on a solid medium (hereinafter referred to as CA medium) containing C medium and 2 g/dl agar. Culture this at 30°C for 2 days, and spread the resulting colonies (approximately 6000) onto the following three types of solid media using the replica method. CA medium CLA medium: After heat sterilizing the CA medium and cooling it until the temperature of the medium drops to 45℃, 200mg/
A medium supplemented with lysozyme so that MA medium: glucose 10g/, NH 4 Cl4
g/, urea 2g/, KH 2 PO 4 1g/,
K 2 HPO 4 3g/, FeSO 4・7H 2 O 10mg/,
MgSO 4・7H 2 O 400mg/, MnCl 2・4H 2 O 2
mg/, ZnSO 4・7H 2 O 0.9mg/, CuSO 4・
5H 2 O 0.4mg/, Na 2 B 4 O 7・10H 2 O 0.09mg/
, (NH 4 ) 6 Mo 7 O 24・4H 2 O 0.04 mg/, biotin 30 μg/, thiamine hydrochloride 1 mg/,
Cysteine hydrochloride 20mg/and agar 20g/
A medium with the composition (PH7.0 before sterilization). After culturing at 30℃ for 2 days, CLA was grown on CA medium.
Bacteria that do not grow in the medium are obtained as lysozyme-sensitive mutants. Out of 6,000 colonies tested, 110 autotrophic, lysozyme-sensitive mutants that grew similarly to the parent strain on MA medium were obtained. this
17 out of 110 strains produced large amounts of L- even in biotin-rich medium.
It had the ability to grow glutamic acid. Corynebacterium glutamicum KY9703 and
KY9705 is an example of a mutant strain thus obtained. Mutation induction using Brevibacterium flavum ATCC14067 as the parent strain was performed in the same manner as above to obtain Brevibacterium flavum KY9733. The above-mentioned mutant strains, MA medium, CA medium, CLA
Table 1 shows the results of comparison with the parent strain regarding growth in the medium and sensitivity to lysozyme. Growth on three types of solid media was done using the replica method and grown at 30°C.
Judgment was made after culturing for 2 days. In the growth column in the table, + indicates that bacterial growth was observed, and - indicates that no growth was observed. In addition, lysozyme sensitivity in the table was tested as follows. That is, in C medium for 24 hours.
After collecting the bacteria cultured with liquid shaking at 30°C, dilute appropriately with physiological saline to create a suspension of the bacteria. This suspension, equivalent to 10 4 cells, is inoculated dropwise into a CA medium containing lysozyme at multiple concentrations and cultured at 30° C. for 2 days. The minimum lysozyme concentration at which the growth of bacteria could not be stopped was defined as the lysozyme susceptibility value (minimum growth-inhibiting concentration) of bacteria.
【表】
本発明の微生物を培養するための培地は、炭素
源、窒素源、無機化合物、その他の栄養素を適当
に含む培地ならば、通常L−グルタミン酸生産に
用いられる天然培地、合成培地のいずれも使用で
きる。たとえば炭素源としては蔗糖、ブドウ糖、
糖蜜などの糖質および殿粉糖化液などが、窒素源
としてはアンモニア、硫酸アンモニウム、塩酸ア
ンモニウム、硫酸アンモニウム、燐酸アンモニウ
ム、炭酸アンモニウム、水酸化アンモニウム、ク
エン酸アンモニウム、酒石酸アンモニウム、酢酸
アンモニウム、尿素などの有機無機窒素化合物、
ペプトン、肉エキス、コーンスチープリカーなど
の天然栄養源などが、無機化合物としては燐酸第
一カリ、燐酸第二カリ、硫酸カリ、硫酸マグネシ
ウム、塩化マグネシウム、硫酸第一鉄、塩化第二
鉄、硫酸マンガン、塩化マンガンなどが、その他
の栄養源としてはビオチン、サイアミンなどが用
いられる。
培養は振盪培養、通気撹拌培養などの好気的条
件で行い、培養温度は24〜37℃とくに28〜33℃が
好適である。培養中は適当な中和剤を用いてPHを
6〜9に調整るのが好ましい。培養は1〜3日間
行えば培養液中に著量のL−グルタミン酸が生成
蓄積する。培養液からのL−グルタミン酸の採取
は、菌体を除去した上清液から、イオン交換樹脂
による吸脱着法、濃縮晶析法、等電点晶析法な
ど、従来のL−グルタミン酸の製造において常用
される諸方法を適宜使用して行うことができる。
以下に本発明の実施例を示す。
実施例 1
グルコース40g/、(NH4)2SO4 2g/、
MgSO4・7H2O 0.5g/、KH2PO4 0.5g/、
K2HPO4 1g/、FeSO4・7H2O 2mg/、
MnSO4・4H2O 2mg/、サイアミン塩酸塩
1mg/、フエノールレツド10mg/およびビオ
チン2μg/あるいは100μg/の組成を有す
る培地を調製し、PHを7.0に調整した後、30mlず
つ300ml容の枝付フラスコに入れ、115℃で15分間
加熱殺菌した。冷却後、別に加熱殺菌した尿素液
を2g/になるように添加した。この培地に第
2表に示した菌を接種し30℃で振盪培養を行つ
た。培養中培養液をPH6.5〜8.0に保つため12時間
目と20時間目の2回尿素液を4g/になるよう
に添加し、32時間で培養を終了した。かくして培
養液中に蓄積したL−グルタミン酸量は、第2表
に示す通りである。培養液1から菌体を除去
し、濃縮し、塩酸でPH3.2に調整し、冷却してL
−グルタミン酸の粗結晶を得た。粗結晶の量
(g)を括孤内に示す。[Table] The medium for culturing the microorganism of the present invention may be either a natural medium or a synthetic medium normally used for L-glutamic acid production, as long as it contains an appropriate amount of carbon sources, nitrogen sources, inorganic compounds, and other nutrients. can also be used. For example, carbon sources include sucrose, glucose,
Carbohydrates such as molasses and saccharified starch liquid are used as nitrogen sources, while organic substances such as ammonia, ammonium sulfate, ammonium hydrochloride, ammonium sulfate, ammonium phosphate, ammonium carbonate, ammonium hydroxide, ammonium citrate, ammonium tartrate, ammonium acetate, and urea are used as nitrogen sources. inorganic nitrogen compounds,
Natural nutritional sources such as peptone, meat extract, corn steep liquor, etc., and inorganic compounds such as potassium phosphate, potassium phosphate, potassium sulfate, magnesium sulfate, magnesium chloride, ferrous sulfate, ferric chloride, and sulfuric acid. Manganese, manganese chloride, etc. are used, and biotin, thiamine, etc. are used as other nutritional sources. The culture is carried out under aerobic conditions such as shaking culture and aerated agitation culture, and the culture temperature is preferably 24 to 37°C, particularly 28 to 33°C. During cultivation, it is preferable to adjust the pH to 6 to 9 using a suitable neutralizing agent. If the culture is continued for 1 to 3 days, a significant amount of L-glutamic acid will be produced and accumulated in the culture solution. L-glutamic acid can be collected from the culture solution using conventional methods for producing L-glutamic acid, such as adsorption/desorption using an ion exchange resin, concentration crystallization, and isoelectric focusing from the supernatant after removing bacterial cells. This can be carried out using various commonly used methods as appropriate. Examples of the present invention are shown below. Example 1 Glucose 40g/, (NH 4 ) 2 SO 4 2g/,
MgSO 4・7H 2 O 0.5g/, KH 2 PO 4 0.5g/,
K 2 HPO 4 1g/, FeSO 4・7H 2 O 2mg/,
MnSO 4 4H 2 O 2mg/, thiamine hydrochloride
Prepare a medium with a composition of 1mg/1mg/phenol, 10mg/biotin, and 2μg/or 100μg/biotin, adjust the pH to 7.0, put 30ml into a 300ml side-end flask, and heat sterilize at 115℃ for 15 minutes. did. After cooling, a separately heat-sterilized urea solution was added to the solution at a concentration of 2 g. The bacteria shown in Table 2 were inoculated into this medium and cultured with shaking at 30°C. In order to maintain the pH of the culture solution during culture at 6.5 to 8.0, urea solution was added twice at 12 hours and 20 hours at a concentration of 4 g/hour, and the culture was completed after 32 hours. The amount of L-glutamic acid thus accumulated in the culture solution is as shown in Table 2. Remove the bacterial cells from culture solution 1, concentrate, adjust the pH to 3.2 with hydrochloric acid, cool, and
- Crude crystals of glutamic acid were obtained. The amount (g) of crude crystals is shown in parentheses.
【表】
実施例 2
実施例1で用いた培地中グルコースを甘蔗廃糖
蜜(グルコースとして40g/相当量)に換え、
加熱殺菌後の培地をPH7.0に再調整する以外は実
施例1と同様に行つた。培養液中に蓄積したL−
グルタミン酸量を第3表に示す。[Table] Example 2 The glucose in the medium used in Example 1 was replaced with cane molasses (40 g/equivalent amount as glucose),
The same procedure as in Example 1 was carried out except that the medium after heat sterilization was readjusted to pH 7.0. L- accumulated in the culture solution
The amount of glutamic acid is shown in Table 3.
Claims (1)
レビバクテリウム・フラブムに属し、リゾチーム
感受性を有し、培地中に存在する過剰のビオチン
によつてL−グルタミン酸の生産が抑制されない
性質を有する微生物。 2 該微生物がコリネバクテリウム・グルタミク
ムKY9703(微工研菌寄第4412、NRRL11271)、
コリネバクテリウム・グルタミクムKY9705(微
工研菌寄第4413、NRRL11272)またはブレビバ
クテリウム・フラブムKY9733(微工研菌寄第
4414、NRRL11273)である特許請求の範囲第1
項記載の微生物。[Scope of Claims] 1. A microorganism that belongs to Corynebacterium glitamicum or Brevibacterium flavum, is sensitive to lysozyme, and has the property that the production of L-glutamic acid is not inhibited by excess biotin present in the culture medium. . 2. The microorganism is Corynebacterium glutamicum KY9703 (Feikoken Bacteria No. 4412, NRRL11271),
Corynebacterium glutamicum KY9705 (FER 4413, NRRL11272) or Brevibacterium flavum KY9733 (FER)
4414, NRRL11273)
Microorganisms listed in section.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18606186A JPS6244171A (en) | 1986-08-07 | 1986-08-07 | Novel bacterium capable of producing l-glutamic acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18606186A JPS6244171A (en) | 1986-08-07 | 1986-08-07 | Novel bacterium capable of producing l-glutamic acid |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2882178A Division JPS54122794A (en) | 1978-03-14 | 1978-03-14 | Preparation of l-glutamic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6244171A JPS6244171A (en) | 1987-02-26 |
| JPH0354550B2 true JPH0354550B2 (en) | 1991-08-20 |
Family
ID=16181705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP18606186A Granted JPS6244171A (en) | 1986-08-07 | 1986-08-07 | Novel bacterium capable of producing l-glutamic acid |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6244171A (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2191710T3 (en) * | 1994-08-19 | 2003-09-16 | Ajinomoto Kk | PROCEDURE TO PRODUCE L-LISINE AND L-GLUTAMIC ACID BY FERMENTATION. |
| JP4184606B2 (en) * | 1998-09-04 | 2008-11-19 | 協和醗酵工業株式会社 | New gene |
| KR102254635B1 (en) * | 2021-01-27 | 2021-05-21 | 씨제이제일제당 주식회사 | Novel glucosamine-6-phosphate deaminase variant and a method for producing L-glutamic acid using the same |
-
1986
- 1986-08-07 JP JP18606186A patent/JPS6244171A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6244171A (en) | 1987-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR960016135B1 (en) | Process for producing l-isoleucine | |
| JP3006926B2 (en) | Method for producing L-threonine by fermentation method | |
| JPH04112795A (en) | Production of l-tryptophan by fermentation method | |
| JPH0488994A (en) | Production of l-glutamine by fermentation | |
| JPS6236676B2 (en) | ||
| US5492818A (en) | Method of producing L-glutamic acid by fermentation | |
| JPS62195293A (en) | Production of l-isoleucine by fermentation method | |
| US5460958A (en) | Process for producing L-isoleucine by S-2-aminoethyl-L-cysteine or D-Serine resistant strains of E coli | |
| JP2578492B2 (en) | Method for producing L-threonine by fermentation method | |
| JPH0354550B2 (en) | ||
| JP2578463B2 (en) | Production method of L-lysine by fermentation method | |
| JPH0129555B2 (en) | ||
| JPH057493A (en) | Production of l-valine by fermentation | |
| JPS6249038B2 (en) | ||
| JPS6155958B2 (en) | ||
| JPS5838153B2 (en) | Hatsukouhou Niyoramino Sanno Seizouhou | |
| EP0076516B1 (en) | Method for fermentative production of l-proline | |
| JPS6227798B2 (en) | ||
| JP2877414B2 (en) | Method for producing L-threonine by fermentation | |
| US5034319A (en) | Process for producing L-arginine | |
| JP3006907B2 (en) | Method for producing L-alanine by fermentation method | |
| JP2574786B2 (en) | Method for producing L-threonine | |
| JPH029384A (en) | Production of l-glutamic acid by fermentation process | |
| JPH0692A (en) | Production of l-arginine by fermentation method | |
| JPS62265988A (en) | Production of l-arginine by fermentation |